From professional translators, enterprises, web pages and freely available translation repositories.
the acellular pertussis vaccine components are obtained by extraction and purification from phase i bordetella pertussis cultures, followed by irreversible detoxification of the pertussis toxin by glutaraldehyde and formaldehyde treatment, and formaldehyde treatment of filamentous haemagglutinin and pertactin.
de acellulære pertussis-vaccinekomponenter er fremstillet ved ekstraktion og oprensning af fase i bordetella pertussis kulturer, hvor pertussis-toxinet efterfølgende er irreversibelt detoxificeret ved hjælp af behandling med glutaraldehyd og formaldehyd, samt formaldehydbehandling af filamentøs hæmagglutinin og pertactin.
to any ingredients listed in section 6, to neomycin, streptomycin or polymyxin b (antibiotics), glutaraldehyde or formaldehyde, as these substances are used during the manufacturing process.
over for et af de øvrige indholdsstoffer (angivet i afsnit 6), over for neomycin, streptomycin eller polymyxin b (antibiotika), glutaraldehyd eller formaldehyd, da disse stoffer anvendes i fremstillingsprocessen.
hypersensitivity to the active substances, to any of the excipients listed in section 6.1, to trace residuals (glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin b), to any pertussis vaccine, or after previous administration of hexacima or a vaccine containing the same components or constituents.
overfølsomhed over for de aktive stoffer, over for ethvert af hjælpestofferne, anført i punkt 6.1, over spor af residualstoffer (glutaraldehyd, formaldehyd, neomycin, streptomycin og polymyxin b), over for en pertussis vaccine, over for en tidligere administration af hexacima eller en vaccine, der indeholder de samme indholdsstoffer eller bestanddele.